Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2022

Feb 12, 2022

29745_dirs_2022-02-11_0b637e83-4cae-4162-af8f-7de20e656415.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2022-02-09

Reporting Person: Pusey Leigh Ann (SVP, Corp. Affairs & Comm.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-02-09 Common Stock A 5309 $243.27 Acquired 26244 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-02-09 Restricted Stock Unit $ A 3154 Acquired 2023-02-01 Common Stock (3154.0) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.